|
AG 205
|
cis-5-({[1-(4-chlorophenyl)-1H-tetraazol-5-yl]sulfanyl}acetyl)-2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole
|
442656-02-2
|
|
Alatrofloxacin Mesylate
|
甲磺酸阿拉曲伐沙星
|
146961-77-5
|
|
AG-5507
|
|
294865-05-7
|
|
AHR Antagonist 5
|
(R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine
|
2247953-39-3
|
|
AL-3803
|
化合物 T29816
|
145555-03-9
|
|
AGN 195183
|
367273-07-2
|
367273-07-2
|
|
AL-034
|
|
|
|
Alclometasone Dipropionate
|
阿氯米松雙丙酸酯
|
66734-13-2
|
|
Alflutinib mesylate
|
AST2818甲磺酸鹽
|
2130958-55-1
|
|
AG-14361
|
AG14361
|
328543-09-5
|
|
albutrepenonacog alfa
|
|
|
|
Aldometanib
|
化合物ALDOMETANIB
|
2904601-67-6
|
|
AGN 194310
|
CS-1211
|
229961-45-9
|
|
ALK-IN-12
|
ALK-IN-12
|
1197958-53-4
|
|
AG-1557 hydrochloride
|
|
|
|
AKT-IN-2
|
AKT-IN-2
|
1295514-91-8
|
|
Alkannin
|
阿卡寧
|
23444-65-7
|
|
AGN 192836
|
AGN192836
|
171102-29-7
|
|
ALK inhibitor 2
|
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761438-38-4
|
|
ALK4290
|
BI-144807
|
1251528-23-0
|
|
Aldicarb sulfone
|
得滅克,丁醛肟威
|
1646-88-4
|
|
Alisertib sodium
|
ALISERTIB SODIUM
|
1028486-06-7
|
|
AG-041R
|
2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide
|
159883-95-1
|
|
AG-1024
|
AG1024
|
65678-07-1
|
|
Alexidine
|
己聯(lián)雙辛胍
|
22573-93-9
|
|
AKI603
|
AKI-603
(AKI603)
|
1432515-73-5
|
|
AHU-377 hemicalcium salt
|
LCZ696中間體
|
1369773-39-6
|
|
AG-1801
|
AG-1801
|
204010-55-9
|
|
Ajugol
|
益母草苷A
|
52949-83-4
|
|
ALK2-IN-4
|
無中文名稱
|
2248154-85-8
|
|
Ajoene
|
CIS-4,5,9-TRITHIADODECA-1,6,11-TRIENE-9-
|
92285-01-3
|
|
AL 6598
|
AL 6598
|
170291-06-2
|
|
AGN 210676
|
AGN 210676
|
910562-15-1
|
|
Aladorian
|
Aladorian
|
865433-00-7
|
|
AG-636
|
AG-636
|
1623416-31-8
|
|
AL 082D06
|
AL 082D06游離態(tài)
|
256925-03-8
|
|
AKT-IN-11
|
化合物 AKT-IN-11
|
|
|
AG-1812 Free base
|
化合物 T29704
|
700341-80-6
|
|
AGN 205728
|
CS-1209
|
859498-05-8
|
|
AHR antagonist 4
|
AHR antagonist 4
|
2242465-58-1
|
|
Alda 1
|
N-(1,3-苯并二氧雜環(huán)戊烯-5-基甲基)-2,6-二氯苯甲酰胺
|
349438-38-6
|
|
ALK2-IN-4 succinate
|
ALK2-IN-4 SUCCINATE
|
2416307-25-8
|
|
Alafosfalin
|
阿拉磷
|
60668-24-8
|
|
ALK-IN-5
|
ALK-IN-5
|
2351929-66-1
|
|
AG-370
|
TYRPHOSTIN B7
|
134036-53-6
|
|
AKT-IN-3
|
AKT-IN-3
|
2374740-21-1
|
|
AG-82
|
酪氨酸磷酸化抑制劑25
|
118409-58-8
|
|
AG957
|
AG 957
|
140674-76-6
|
|
AGI-5198
|
AGI-5198 (IDH-C35)
|
1355326-35-0
|
|
AH 6809
|
6-異丙氧基-9-氧代氧雜蒽-2-羧酸
|
33458-93-4
|
|
Alalevonadifloxacin
|
(S)-8-[4-[[(S)-2-氨基丙?；鵠氧基]-1-哌啶基]-9-氟-5-甲基-1-氧代-1,5,6,7-四氫吡啶并[3,2,1-IJ]喹啉-2-甲酸
|
706809-20-3
|
|
Alirocumab
|
阿利庫單抗
|
1245916-14-6
|
|
AGN 196996
|
CS-1210
|
958295-17-5
|
|
AIM-100
|
5,6-二苯基-N-[[(2S)-四氫-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺
|
873305-35-2
|
|
AL-3152
|
AL 3152
|
126048-33-7
|
|
Akt-I-1,2 HCl
|
BenzeneMethanaMine, α,α-diMethyl-4-(3-phenyl-2-quinoxalinyl)-, Monohydrochloride (9CI)
|
473382-50-2
|
|
ALK inhibitor 1
|
2-[[5-溴-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761436-81-1
|
|
AGN 205327
|
CS-1208
|
|
|
ALE-0540
|
ALE-0540
|
234779-34-1
|
|
Aganepag isopropyl
|
Aganepag isopropyl
|
910562-20-8
|
|
Aligeron
|
ALIGERON
|
70713-45-0
|
|
Alfuzosin
|
阿夫唑嗪
|
81403-80-7
|
|
AG-183
|
酪氨酸磷酸化抑制劑A51
|
122520-90-5
|
|
AL 8810 isopropyl ester
|
9ALPHA,15R-DIHYDROXY-11BETA-FLUORO-15-(2,3-DIHYDRO-1H-INDEN-2-YL)-16,17,18, 19,20-PENTANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER
|
208114-93-6
|
|
Aldose reductase-IN-1
|
AT-001
|
1355612-71-3
|
|
ALK-IN-9
|
ALK-IN-9
|
2359662-39-6
|
|
AG2000 Free Base
|
AG2000 Free Base
|
111712-15-3
|
|
AICAR phosphate
|
5-氨基-1-核糖基咪唑-4-甲酰胺磷酸鹽
|
681006-28-0
|
|
AG 494
|
|
139087-53-9
|
|
Alibendol
|
阿利苯多
|
26750-81-2
|
|
ALK/ROS1-IN-1
|
ALK/ROS1-IN-1
|
2365497-07-8
|
|
AG-18
|
酪氨酸磷酸化抑制劑23
|
118409-57-7
|
|
AG-1478
|
AG1478
|
153436-53-4
|
|
AH3960
|
化合物AH-3960
|
862907-48-0
|
|
AKTide-2T TFA
|
|
|
|
Aganepag
|
AGANEPAG
|
910562-18-4
|
|
ALB 109564(a) dihydrochloride
|
ALB 109564(a) dihydrochloride
|
1300114-12-8
|
|
AHR antagonist 2
|
AHR antagonist 2
|
2338747-54-7
|
|
Akt-I-1
|
N3-(7-環(huán)丁基-3-苯基-1,2,4-三唑并[4,3-B]噠嗪-6-基)-N1,N1,2,2-四甲基-1,3-丙二胺
|
473382-39-7
|
|
AH 23848 calcium salt
|
(4Z)-7-[(REL-1S,2S,5R)-5-((1,1'-BIPHENYL-4-YL)METHOXY)-2-(4-MORPHOLINYL)-3-OXOCYCLOPENTYL]-4-HEPTENOIC ACID CALCIUM SALT
|
81496-19-7
|
|
AlbA-DCA
|
|
2413716-79-5
|
|
AGN 194078
|
321995-62-4
|
321995-62-4
|
|
AHR antagonist 5 free base
|
化合物AHR ANTAGONIST 5 FREE BASE
|
2247950-42-9
|
|
AGL 2263
|
AG 2263
|
638213-98-6
|
|
AhR modulator-1
|
|
118174-38-2
|
|
Aglafoline
|
143901-35-3
|
143901-35-3
|
|
AG-7404
|
AG-7404
|
343565-99-1
|
|
AHR antagonist 5 hemimaleate
|
化合物 AHR ANTAGONIST 5 HEMIMALEATE
|
|
|
Alifedrine hydrochloride
|
|
72913-80-5
|
|
AKOS B018304
|
AKOS B018304
|
6308-22-1
|
|
ALK-IN-13
|
ALK-IN-13
|
1197953-88-0
|
|
AKT-IN-5
|
化合物 AKT-IN-5
|
1402608-05-2
|
|
AG 1812
|
化合物 T29697
|
114559-57-8
|
|
AGN 203818
|
|
1021954-16-4
|
|
AG28262
|
化合物 T29706
|
638216-89-4
|
|
AL-611
|
AL-611
|
1613591-70-0
|
|
AL-321
|
化合物 T29815
|
74772-68-2
|
|
AH 001
|
N-(1,2,3,4-四氫-8-甲氧基-2-萘基)乙酰胺
|
80270-68-4
|
|
AG-213
|
酪氨酸磷酸化抑制劑
|
122520-86-9
|
|
Akt Inhibitor IV
|
6-(2-苯并噻唑基)-1-乙基-2-[2-(甲基苯基氨基)乙烯基]-3-苯基-1H-苯并咪唑碘化物
|
681281-88-9
|